Medindia LOGIN REGISTER
Medindia

Side effect(s) of Enasidenib


Review the side-effects of Enasidenib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  Common:
Increased level of bilirubin, reduced calcium or potassium levels in blood, nausea, vomiting, diarrhea

  Gastrointestinal:
Loss of appetite, stomach pain

  Cardiovascular:
Irregular heart rhythm

  Respiratory:
Difficulty in breathing, hypoxia, acute respiratory distress syndrome, pulmonary edema (fluid accumulation in the lung), lung failure

  Blood:
Differentiation syndrome, non-infectious leucocytosis

  Skin:
Yellowish coloration of the skin, rashes, itching, blistering or peeling of the skin

  Others:
Fever, jaundice, weight loss, tumor lysis syndrome, taste disturbances, increased blood uric acid levels, reduced phosphorous levels in the blood

Other Precautions :

• Do not stop taking or alter the dose without physician’s advice.
• Drink plenty of water or any other fluids as advised while on enasidenib treatment.
• Women of childbearing age should take a pregnancy test before enasidenib therapy and can continue the treatment only if the test shows negative.
• Call for emergency help if the victim is not breathing or collapsed.

Drug Name : Enasidenib

Enasidenib generic Enasidenib is an isocitrate dehydrogenase 2 inhibitor. It is prescribed to treat acute myeloid leukemia in adult patients who have not responded to treatment or relapsed following treatment and are positive for isocitrate dehydrogenase-2 mutation as detected by an FDA approved test. Acute myeloid leukemia is a type of cancer that that arises from the white blood cells. Enasidenib works by either reducing or blocking the growth of the cancer cells.


Advertisement